Skip to main content


Browse the latest news, expert commentary, and educational content on lupus.


12-01-2021 | COVID-19 | Podcast | Article

Repurposing rheumatology drugs for COVID-19: Hydroxychloroquine

Alfred Kim talks about the initial promise of hydroxychloroquine for COVID-19 and why it did not stand up to later scrutiny (13:06).

06-01-2021 | Systemic lupus erythematosus | News

Hydroxychloroquine blood monitoring may predict thrombosis risk in SLE

Among patients with systemic lupus erythematosus receiving treatment with hydroxychloroquine, low drug levels in the blood are associated with an elevated risk for arterial and venous thrombosis events, researchers report.

08-11-2020 | ACR 2020 | Conference coverage | News

BIIB059 improves active total joint count in systemic lupus erythematosus

BIIB059, a monoclonal antibody that binds blood dendritic cell antigen 2 and inhibits interferon 1, improves total active joint count at 24 weeks in patients with systemic lupus erythematosus, findings from the LILAC trial show.

More on lupus treatments

02-02-2021 | Lupus nephritis | News

Voclosporin approved for lupus nephritis in the USA

Click through for more details on this approval

01-02-2021 | COVID-19 | News

COVID-19 may be a risk factor for rheumatic disease flare

Having COVID-19 is associated with an increased risk for flare among Latino patients with rheumatic diseases, researchers report.

18-01-2021 | Lupus nephritis | News

FDA approves belimumab for lupus nephritis

Click through for more information on this announcement

Keep up with podcasts on this topic, available on

Stay informed with Medicine Matters

Get the latest developments in rheumatology delivered straight to your inbox

Image Credits